LTRN
Lantern Pharma Inc.$3.05-0.01 (-0.33%)Prev Close$3.07·MCap$29.9M·P/E—·Vol76.6K·Yield—
▲
Buys (12M)
2
$220.4K
▼
Sells (12M)
0
$0.00
◆
Net Activity
Net Buyer
$220.4K
●
Active Insiders
2
last 12 mo
Over the past 12 months, insider activity at Lantern Pharma Inc. (LTRN) has been exclusively buying, with 2 insider purchases totaling $220.4K and 0 insider sales totaling $0.00. The most recent insider transaction was by Schalop Lee Troy (director), who purchased $110.2K worth of shares on May 14, 2026. Lantern Pharma Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $29.9M.
LTRN Insider Trading Activity
LTRN Insider Buying Activity
The following table shows recent insider purchases of Lantern Pharma Inc. (LTRN) stock reported via SEC Form 4 filings.
LTRN Insider Selling Activity
The following table shows recent insider sales of Lantern Pharma Inc. (LTRN) stock reported via SEC Form 4 filings.